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da Silva LG, Rodrigues Dias AC, Furlan E, Colombari E. Nitric
oxide modulates the cardiovascular effects elicited by acetylcholine in
the NTS of awake rats. Am J Physiol Regul Integr Comp Physiol
295: R1774–R1781, 2008. First published September 24, 2008;
doi:10.1152/ajpregu.00559.2007.—Microinjection of acetylcholine
chloride (ACh) in the nucleus of the solitary tract (NTS) of awake rats
caused a transient and dose-dependent hypotension and bradycardia.
Because it is known that cardiovascular reflexes are affected by nitric
oxide (NO) produced in the NTS, we investigated whether these
ACh-induced responses depend on NO in the NTS. Responses to ACh
(500 pmol in 100 nl) were strongly reduced by ipsilateral microinjec-
tion of the NOS inhibitor NG-nitro-L-arginine methyl ester (L-NAME;
10 nmol in 100 nl) in the NTS: mean arterial pressure (MAP) fell by
50  5 mmHg before L-NAME to 9  4 mmHg, 10 min after
L-NAME, and HR fell by 100  26 bpm before L-NAME to 20  10
bpm, 10 min after L-NAME (both P  0.05). Microinjection of the
selective inhibitor of neuronal nitric oxide synthase (nNOS), 1-(2-
trifluoromethylphenyl) imidazole (TRIM; 13.3 nmol in 100 nl), in the
NTS also reduced responses to ACh: MAP fell from 42  3 mmHg
before TRIM to 27 6 mmHg, 10 min after TRIM (P 0.05). TRIM
also tended to reduce ACh-induced bradycardia, but this effect was
not statistically significant. ACh-induced hypotension and bradycar-
dia returned to control levels 30–45 min after NOS inhibition.
Control injections with D-NAME and saline did not affect resting
values or the response to ACh. In conclusion, injection of ACh into
the NTS of conscious rats induces hypotension and bradycardia, and
these effects may be mediated at least partly by NO produced in NTS
neurons.
cholinergic transmission; nitric oxide synthase inhibition; nucleus of
the solitary tract; cardiovascular control
THE NUCLEUS OF THE SOLITARY tract (NTS) is the primary site of
cardiovascular afferent termination in the central nervous sys-
tem (CNS) (1). The main neurotransmitter released in the NTS
by terminals of cardiovascular afferents appears to be gluta-
mate (39, 40, 42).
We have previously shown that the effects of glutamate in
the NTS depend partly on locally produced neuronal nitric
oxide (NO). NO increases the number of discharges evoked by
excitatory amino acids in NTS neurons that receive vagal
afferent inputs, and action potentials induced by iontophoretic
application of AMPA in the NTS are reduced by NG-nitro-L-
arginine methyl ester (L-NAME) (10). In addition, the renal
sympathoinhibition induced by activation of baroreceptors and
cardiopulmonary receptors is attenuated by microinjection of
L-NAME in the NTS (11). Therefore, we proposed that the
release of glutamate induced by the activation of cardiovascu-
lar afferents triggers the activation of nNOS in the postsynaptic
neuron. The NO produced may diffuse to adjacent cells and
increase the release of glutamate and other neurotransmitters.
The specific function or mechanism of this interaction remains
to be elucidated. NO plays a second-messenger role, mediating
cyclic guanosine monophosphate (cGMP) synthesis in the
brain. The soluble guanylyl cyclase (sGC) is the target for NO
in the CNS (3, 13, 19, 31, 37). NO is a diffusible compound,
and it may act in the same and/or adjacent cells, changing the
release of other neurotransmitters, such as ACh.
In the present study, we tested whether the cardiovascular
effects of acetylcholine chloride (ACh) in the NTS similarly
depend on NO. Several researchers suggested that ACh in the
NTS may contribute to central autonomic regulation (21, 29,
30). The cholinergic system was identified within neurons and
terminals of the NTS by the presence of acetylcholinesterase
(20, 35), choline acetyltransferase (17, 35), ACh (17), and
muscarinic receptors (20, 35, 47). Nicotinic receptors were
identified by intracellular and extracellular studies on subpopu-
lations of neurons in the NTS (32, 34, 45). However, there have
been few functional in vivo studies, and the role of ACh in the
NTS in cardiovascular regulation is still unclear. ACh micro-
injected into the NTS of anesthetized rats causes hypotension
and bradycardia (6, 41). The hypotensive response to ACh was
blocked by microinjection of atropine, but not hexamethonium
in the NTS (6), suggesting the involvement of muscarinic
receptors. Possibly, the M2 receptors mediate this effect, be-
cause their activation reduced arterial blood pressure and heart
rate (HR) (38). It appears that these receptors are not tonically
stimulated because injection of methylatropine into the NTS
does not increase blood pressure (44). In addition, stimulation
of nicotine receptors in the NTS causes hypotension and
bradycardia (28, 43).
It has been observed that ACh can stimulate the local release
of NO in several brain areas (7), including the hippocampus
(36). Double immunostaining for cGMP and the vesicular ACh
transporter in the rat hippocampus and nucleus ambiguous
suggested that activation of muscarinic receptors (probably M2
receptors) on NOS-containing neurons results in retrograde NO
signaling in some subpopulations of cholinergic fibers (8),
since only a small percentage of NOS-containing neurons
contain muscarinic receptors (25). Activation of NOS through
glutamatergic receptors would result in anterograde signaling
to the remaining cholinergic fibers (8). Cells from the striatum
of nNOS-knockout mice released ACh in the presence of the
NO donor (SIN-1) but not in the presence of the glutamatergic
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agonist (NMDA). This study is evidence that ACh release in
the CNS can be affected by the formation and release of NO
induced by activation of glutamatergic receptors (5).
The cardiovascular effects of microinjection of ACh in the
NTS have not yet been investigated in awake animals. In the
present study, we characterized the cardiovascular effects elic-
ited by microinjection of ACh in the NTS in conscious rats and
investigated whether the inhibition of central NO production in
the NTS affects these responses.
MATERIALS AND METHODS
Animals. Experiments were performed in Male Wistar rats weigh-
ing between 300 and 350 g. Rats were maintained on 12:12-h
light-dark cycle in temperature-controlled rooms, and food and water
were available ad libitum, except during the experiments. During the
experiments, animals were awake and moving freely in the cage. All
experimental protocols were approved by the Institutional Ethics
Committee.
Surgical procedures. Five days before the experiments, rats were
anesthetized with ketamine (50 mg/kg ip, Crista´lia, Itapira, Brazil) and
xylazine 2% (25 mg/kg ip; Virbac, Jurubatuba Sa˜o Paulo Brazil) and
were placed in a stereotaxic frame (model 1940; David Kopf Instru-
ments, Tujunga, CA) with the incisor bar 3.5 mm below the interaural
line. Bilateral guide cannulas (15 mm long) were implanted above the
intermediate NTS, 14.5 mm caudal to the bregma, 0.5 mm lateral to
the midline, and 5.5 mm below the skull surface at the level of bregma
(27). Guide cannulas were fixed with methacrylate to the skull and to
watch screws inserted in the skull. A stainless steel wire closed the
cannula until the beginning of the experiments. Animals were allowed
to recover for 3–5 days.
One day before the experiment, rats were anesthetized with a
mixture of halothane (2%) in oxygen (100%), and a polyethylene
catheter (PE-10 connected to PE-50; Clay Adams, Parsippany, NJ)
was introduced in the femoral artery. The arterial catheter was
tunneled subcutaneously and exteriorized at the back of the neck. All
procedures were performed with sterile tools and solutions. Animals
that appeared to show distress or pain after surgery were euthanized.
Measurement of blood pressure. To measure pulsatile arterial blood
pressure, mean arterial pressure (MAP), and HR, the arterial catheter
of the conscious rat was connected to a Statham P23Db transducer
(Statham Instruments, Hato Rey, Puerto Rico). Signals were amplified
with an ETH-200 Bridge amplifier (CB Sciences, Dover, NH), digi-
tized with a Power Lab 4SP (AD Instruments, Colorado Springs, CO),
and stored and analyzed on a Macintosh G3 computer (Apple) with
Chart 4.1.1 software.
Drugs and drug administration. Injected drugs include the nonse-
lective cholinergic agonist ACh (Sigma, St. Louis, MO), the NOS
inhibitor L-NAME (Sigma), the inactive negative enantiomer of L-
NAME, NG-nitro-D-arginine methyl ester (D-NAME; Sigma), and the
selective inhibitor of neuronal NOS 1-(2-Trifluoromethylphenyl) Im-
idazole (TRIM; Sigma). All drugs were dissolved in saline (0.9%
NaCl), and the pH was adjusted to 7.4 with NaOH.
Drugs were microinjected unilaterally into the intermediate NTS
with a 1-l syringe (Hamilton, Reno, NV) that was connected with
PE-10 tubing to a stainless-steel injection needle with an outer
diameter of 0.2 mm. The injection needle protruded 1.5 mm beyond
the tip of the guide cannula. The volume of all injections was 100 nl.
Protocols. Microinjections started after baseline MAP and HR
were established. Cardiovascular effects elicited by unilateral micro-
injection of ACh (500 pmol/100 nl) in the NTS were determined
before, and 10, 20, and 30 to 45 min after ipsilateral microinjection of
L-NAME (10 nmol in 100 nl) or D-NAME (10 nmol in 100 nl), TRIM
(13.3 nmol in 100 nl), or 100 nl 0.9% saline in the NTS. A maximum
of five microinjections were performed in each animal.
The dose of ACh (500 pmol/100 nl) used in this study was based
in previous studies of the literature (6) and in the dose-response curve
in awake rats presented in this manuscript. This dose caused cardio-
vascular changes similar to baroreflex activation. The dose of
L-NAME and D-NAME (10 nmol/100 nl) used was based on our
previous studies in awake (9) and anesthetized rats. We have shown
before that microinjection of 10 nmol/100 nl of L-NAME into the NTS
does not change resting blood pressure, heart rate, regional blood
flow, and renal sympathetic nerve activity (11), or resting neuronal
discharge of vagus-nerve evoked NTS neurons (10).
The dose of TRIM (13.3 nmol/100 nl) was chosen on the basis of
Scislo et al. (33) and previous studies from our laboratory. This dose
reduced ACh-induced responses without changing baseline blood
pressure and heart rate, and this inhibition was transient. In some of
the experiments, we tried higher concentrations of TRIM, and it
increased the resting blood pressure and caused total blockade of the
ACh response without a recovery, probably because of neuronal
damage.
Histology. After the experiments, methylene blue (100 nl of a 2%
solution) was microinjected in the same NTS site. Animals were
anesthetized with urethane (400 mg/ml ip) and perfused transcardially
with 0.9% saline, followed by 10% formalin solution. The brain was
removed and stored in buffered formalin for at least 2 days before
40-m coronal sections were made with a microtome. Slices were
stained by the Nissl method (Neutral red) (16). Only rats whose
microinjection site was located in the intermediate NTS were used for
data analysis. A typical example of the injection site is shown in Fig. 1.
Data analysis. Peak changes in MAP and HR induced by micro-
injection of ACh were measured. All data were expressed as means
SE and were analyzed with SigmaStat statistical software (ver. 2.03;
SPSS, Chicago, IL). To compare differences between time points, we
used one-way ANOVA with repeated measures, followed by New-
man-Keuls post hoc test. Significance was accepted at P  0.05.
RESULTS
Changes in MAP and HR elicited by microinjection of ACh
in the NTS. Unilateral microinjections of ACh into the NTS of
awake rats elicited hypotension and bradycardia in a dose-
dependent manner. Injections of 0.1, 1.0, and 10 pmol ACh in
100 nl did not significantly reduce MAP and HR (n  9,
Fig. 2A). However, in a second group of rats, the 100 pmol in
a 100-nl dose elicited hypotension (28  7 mmHg) and
bradycardia (61  14 bpm; P  0.05, n  7). Higher doses
Fig. 1. Photomicrograph of a coronal section of the brain stem showing a
typical unilateral injection site in the NTS. Arrow indicates the center of
microinjection. AP, area postrema; cc, central canal, X, dorsal motor nucleus
of vagus; XII, hypoglossal nucleus, NTS, nucleus of the solitary tract. Scale
bar  1 mm.
R1775NO AND ACETYLCHOLINE IN THE NTS
AJP-Regul Integr Comp Physiol • VOL 295 • DECEMBER 2008 • www.ajpregu.org
of ACh were more effective (500 pmol reduced MAP by 34 
3 mmHg and HR by 93  11 bpm, and 1,000 pmol reduced
MAP by 55  6 mmHg and HR by 104  15 bpm; P  0.05,
n  7, Figs. 2B and 3). The injections did not cause obvious
behavioral or respiratory activation.
To test whether ACh-induced hypotension was secondary to
bradycardia, we assessed cardiovascular responses to microin-
jection of ACh (500 pmol/100 nl) before and 20 min after
intravenous injection of the muscarinic receptor antagonist
methylatropine (1 mg/kg). The bradycardia induced by ACh
fell from 144  18 bpm before methylatropine to 6  2 bpm
after methylatropine (P  0.05, n  5), but methylatropine did
not reduce the ACh-induced hypotension (41  1 mmHg
before methylatropine, 39  2 mmHg after methylatropine).
Effects of ACh were only observed when microinjections
reached the intermediate NTS; injections in other areas of the
NTS or adjacent sites failed to elicit any response. The sizable
heart rate responses are probably due to the condition of the
experiment performed in awake, freely moving rats.
Effects of NOS inhibition with L-NAME on changes in MAP
and HR caused by microinjection of ACh in the NTS. Repeated
unilateral microinjections with ACh (500 pmol in 100 nl) were
made before and after microinjection of L-NAME (10 nmol in
100 nl) into the ipsilateral NTS of conscious rats. L-NAME did
not change baseline MAP (113  4 mmHg before L-NAME;
112  3 mmHg after L-NAME, n  8) or baseline HR (331 
8 bpm before L-NAME; 325  10 bpm after L-NAME,
Fig. 4, A and B). However, L-NAME almost completely
blocked ACh-induced hypotension (50  5 mmHg before
L-NAME, 9  4 mmHg, 10 min after L-NAME, P  0.05) and
bradycardia (100 26 bpm before L-NAME, 20 10 bpm, 10
min after L-NAME, P  0.05). Responses to ACh were still
depressed 20 min after injection of L-NAME and returned to
control values between 30 and 45 min after injection of
L-NAME (Fig. 4B, left).
In a separate group of rats, we injected D-NAME instead of
L-NAME to control for nonspecific effects of L-NAME. Micro-
injection of 10 nmol D-NAME into the NTS did not affect
Fig. 2. Typical recordings showing changes in pulsatile arterial
pressure (PAP), mean arterial pressure (MAP) and heart rate
(HR) elicited by unilateral microinjection of various doses of
acetylcholine into the intermediate NTS of awake rats. A: lower
doses of ACh (100, 0,1, 1, 10, 100 pmol/100 nl; vehicle 0.9%
saline). B: higher doses (100, 500, 1,000 pmol/100 nl). Inj
denotes an artifact caused by insertion of the microinjector into
the guide cannula.
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baseline MAP (118  3 mmHg before D-NAME, 118  2
mmHg after D-NAME, n  7) and HR (337  11 bpm before
D-NAME, 328 12 bpm after D-NAME). D-NAME also failed
to reduce the hypotension and bradycardia induced by micro-
injection of 500 pmol ACh (Fig. 4B, right).
Effect of the nNOS inhibitor TRIM on changes in MAP and
HR caused by microinjection of ACh into the NTS. To inves-
tigate the role of neuronal NOS in the responses to injection of
ACh in the NTS, we used the selective nNOS inhibitor TRIM.
Unilateral microinjection of TRIM (10 nmol in 60 nl) in the
NTS of conscious rats did not change baseline MAP (112  3
mmHg before TRIM, 114  3 mmHg after TRIM) and base-
line HR (339  11 bpm before TRIM, 330  14 bpm after
TRIM, n  8, Fig. 5, A and B). However, TRIM reduced
ACh-induced hypotension (42  3 mmHg before TRIM, 27 
6 mmHg, 10 min after TRIM). TRIM also tended to reduce
ACh-induced bradycardia, but this was not statistically signif-
icant (120  22 bpm before L-NAME; 94  27, 10 min after
TRIM). Responses to ACh were still depressed 20 min after
injection of TRIM and returned to control values between 30
and 45 min after injection of TRIM, Fig. 5B. TRIM appeared
significantly less potent than L-NAME at reducing ACh-in-
duced responses. For example, ACh-induced hypotension was
29  4 mmHg, 20 min after TRIM, and only 6  4 mmHg, 20
min after L-NAME (P  0.05). ACh-induced bradycardia was
94  27 bpm, 20 min after TRIM, and only 20  10 bpm, 20
min after L-NAME (P  0.05).
The effects of the saline vehicle (0.9% NaCl) were tested in
a separate group of six rats. Microinjection of 100 nl saline into
the NTS did not affect baseline MAP (112  2 mmHg before
saline, 113  2 mmHg after saline) and HR (324  18 bpm
before saline, 324  19 bpm after saline). Saline also did not
alter the hypotension and bradycardia induced by ipsilateral
microinjection of 500 pmol ACh (Fig. 5B).
DISCUSSION
In the present study, we determined the cardiovascular
effects elicited by microinjection of ACh in the NTS of awake
rats and whether NO released centrally can modulate these
responses. Although several studies analyzed cholinergic trans-
mission in the NTS and other brain stem areas related to
cardiovascular control, there are no reports in awake rats. We
found that unilateral microinjection of ACh into the NTS of
nonanesthetized rats elicited hypotension and bradycardia.
These responses were reduced after the inhibition of the pro-
duction of NO in the NTS.
Our results are in line with previous findings that showed
that microinjection of ACh and carbachol in the intermediate
NTS produce hypotension and bradycardia in anesthetized rats
(6). The minimal effective dose in rats anesthetized with
halothane (4.4 pmol) is similar to that observed in the awake
rats in our study (10 pmol). The optimal dose was around 500
pmol, both in anesthetized (6) and in awake rats.
The hypotension induced by ACh was not secondary to
reduced heart rate, because blockade of ACh-induced brady-
cardia with methylatropine did not reduce the hypotensive
response. The mechanism that mediates ACh-induced hypo-
tension is not yet clear, but it seems likely that activation of the
cholinergic system in the NTS reduces sympathetic activity.
Despite the fact that all microinjection sites that were histo-
logically located outside the NTS did not elicit any cardiovas-
cular response, we must not exclude the possibility of some
spread of the injection to the dorsal motor nucleus of the vagus.
Since the response induced by ACh (bradycardia and hypoten-
sion) is similar to that induced by baroreceptor activation, it
may be that ACh is part of a mechanism that facilitates
baroreceptor transmission. This idea is also supported by the
finding that NTS neurons containing ACh and choline acetyl-
transferase (ChAT) and activity of ChAT is influenced by
peripheral sinoaortic denervation (26). This mechanism ap-
pears inactive in basal conditions, because the baroreflex is not
affected by blockade of the cholinergic receptors in the NTS
(6, 44). The conditions that stimulate the release of ACh in the
NTS are not yet known.
NO in the NTS has been shown to affect cardiovascular
responses (9, 10, 11). The location of neuronal NOS in the
NTS, juxtaposed to baroreceptor synapses, suggests a role for
NO in the modulation of baroreflex (23). NO is produced by
high-intensity stimulation of glutamate receptors (15). After its
production, it may act in the same or in adjacent cells to
stimulate the release of glutamate through presynaptic recep-
tors (9), and it may also change the release of other neuro-
transmitters such as GABA and substance P.
NO can also affect cholinergic transmission. The histochem-
ical staining NADPH-diaphorase was reported in neurons in a
number of cholinergic nuclei (12, 46), even before NOS was
identified (18). Our results showed that L-NAME could be
blocking ACh responses better than the neuronal NOS inhibitor
(TRIM) compound, because it blocks eNOS and additionally
Fig. 3. Changes in mean arterial pressure (MAP) and heart rate (HR) elicited
by unilateral microinjection of ACh in the NTS of awake rats. For 1 and 10
pmol, n  9; for 100 pmol, n  16; for 500 and 1,000 pmol, n  7. Error bars
indicate means  SE. *P  0.05 with vehicle; P  0.05 with 500 pmol
(Newman-Keuls test).
R1777NO AND ACETYLCHOLINE IN THE NTS
AJP-Regul Integr Comp Physiol • VOL 295 • DECEMBER 2008 • www.ajpregu.org
blocks muscarinic receptors (4). The effect of TRIM suggests
that nNOS contributes to ACh-induced cardiovascular re-
sponses. Similar effects of L-NAME and TRIM on glutama-
tergic transmission were previously observed in modulation of
NTS neurons discharge (10, 24). A study by Scislo et al. (33)
reported that L-NAME and TRIM are equipotent in inhibiting
cardiovascular responses elicited by the stimulation of adeno-
sine A2a receptors in the NTS. However, the dose used in these
experiments was twice the dose used by us. When we tested
this higher dose in our experiments, it increased baseline MAP.
We found this high dose of TRIM highly efficient in reducing
ACh-induced hypotension, but this effect was not reversible.
It is difficult to discriminate effects from each NO source
because nNOS and eNOS are present in adjacent structures in
the NTS (22), and NO diffuses through cell membranes (14). A
recent study from Wang et al. (48) suggested that endothelial
production of NO in the NTS would take place under some
conditions to raise the local concentration of NO to a level that
activates GABAergic inhibition to generate a excitatory-in-
hibitory balance in reflex transmission. Then, the quantity of
NO released from nNOS would have a limited role, mainly
in intracellular pathways of glutamatergic transmission.
On the basis of our results and previous finds in the litera-
ture, we could speculate that the cholinergic transmission in the
NTS (34, 38) involves the activation of a nitroxidergic pathway
that partially produces NO from nNOS and facilitates the
sympathoinhibitory response elicited by ACh microinjection
(Fig. 6). The exact afferent inputs (cardiovascular or others)
that lead to the release of ACh in the NTS are still unknown
(17, 44). Maybe, the cardiovascular inputs to the NTS that
activate glutamatergic transmission, in situations of high-fre-
quency discharge (cardiovascular reflexes activation), also sig-
Fig. 4. Cardiovascular responses to unilateral micro-
injection of ACh (500 pmol/100 nl) into the NTS of
awake rats before and after microinjection of the
NOS inhibitor L-NAME (10 nmol/100 nl) in the
same NTS site. A: typical recordings. ACh-induced
responses were measured before injection of
L-NAME (ACh control), and 10 and 30–45 min after
L-NAME (ACh 10 min and recovery, respectively).
PAP, pulsatile arterial pressure; MAP, mean arterial
pressure; HR, heart rate. B: group data showing
effects of L-NAME (n  8) and the inactive enan-
tiomer D-NAME (10 nmol/100 nl, n  7) on ACh-
induced responses. *P  0.05 with control.
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nal the activation of a cholinergic modulatory pathway. This
signalization could be triggered by NO.
Garthwaite (13) showed that activation of NOS in cholin-
ergic cells can be triggered by activation of NMDA receptors.
Postsynaptic activation of glutamatergic receptors produces
NO that diffuses out of the cell to neighboring cells to activate
sGC in a subpopulation of cholinergic fibers containing mus-
carinic receptors (8).
The methods used by us (microinjections) may affect both
presynaptic and postsynaptic receptors for ACh and NO in the
NTS. cGMP was detected both on the presynaptic and postsyn-
aptic side of the nerve terminal and colocalized with the ACh
vesicular transporter, suggesting that NO may affect both
presynaptic and postsynaptic mechanisms in subsets of cholin-
ergic neurons (7). Neuronal NOS was found in presynaptic and
postsynaptic terminals in the NTS; however, the presynaptic
structures were not of vagal origin, suggesting that second-
order neurons in the NTS or neurons from other regions of the
CNS that use other neurotransmitter systems account for pre-
synaptic nNOS immunoreactivity (2).
The cholinergic receptor subtype that mediates the effect of
ACh in the NTS has not yet been identified. The identification
of the cholinergic receptor subtype that mediates the cardio-
vascular changes induced by microinjection of ACh in the NTS
and the localization of this receptor are crucial in understand-
ing the modulatory role of ACh in blood pressure signaling.
The consequences of increase in cGMP synthesis by NO in
cholinergic fibers of different areas of the CNS remain to be
Fig. 5. Cardiovascular responses to unilateral
microinjection of ACh (500 pmol/100 nl) into
the NTS of awake rats before and after micro-
injection of the selective inhibitor of neuronal
NOS TRIM (10 nmol/100 nl) in the same NTS
site. A: typical recording. ACh-induced re-
sponses were measured before injection of
L-TRIM (ACh control), and 20 and 30–45
min after L-NAME (ACh 20 min and recov-
ery, respectively). PAP, pulsatile arterial pres-
sure; MAP, mean arterial pressure; HR, heart
rate. B: group data showing effects of TRIM
(n  8) and vehicle (100 nl 0.9% saline, n 
6) on ACh-induced responses. *P  0.05 with
control.
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elucidated. The role of ACh and NOS-cGMP activation in the
brain stem nuclei involved in cardiovascular control has re-
ceived little attention so far, but our results are the first
evidence of a functional role for centrally released NO in
cholinergic transmission in the NTS of conscious rats. We
suggest that one of the pathways by which NO can modulate
glutamatergic transmission in the NTS involves the release of
ACh in this nucleus.
Perspectives and Significance
This study characterized the cardiovascular effects elicited
by ACh microinjection within the NTS of awake rats and
showed that NO released in this nucleus from nNOS may
modulate these responses. The findings in the current study are
the first step to physiological investigation of the cholinergic
transmission in the NTS since there are few functional studies
in vivo. Also, NO mechanisms and its integration with gluta-
matergic system in the NTS seem to be complex. Further
investigation is necessary to conclude how ACh produces its
cardiovascular effects and whether this involves the release of
other neurotransmitters. It is a perspective of our study to
understand the relationship of glutamate-NO-ACh systems in
modulation of the cardiovascular reflexes. The subtype of
cholinergic receptor (muscarinic or nicotinic) mediating the
cardiovascular responses induced by microinjection of ACh is
still not clear. The search for differences between subpopula-
tions of NTS neurons with muscarinic and nicotinic receptors
and the specific function of NO during their activation could add
significant information about baroreflex modulation in the NTS.
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